MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ejh.13649

Медицинская библиотека · European journal of haematology · 2021

Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.

Shanmugasundaram Krithika, Goyal Subir, Switchenko Jeffery, Calzada Oscar, Churnetski Michael C, Kolla Bhaskar, Bachanova Veronika, Gerson James N, Barta Stefan K, Gordon Max J, Danilov Alexey V, Grover Natalie S, Mathews Stephanie, Burkart Madelyn, Karmali Reem, Sawalha Yazeed, Hill Brian T, Ghosh Nilanjan, Park Steven I, Epperla Narendranath, Bond David A, Badar Talha, Blum Kristie A, Hamadani Mehdi, Fenske Timothy S, Malecek Mary, Kahl Brad S, Martin Peter, Guo Jin, Flowers Christopher R, Cohen Jonathon B

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

INTRODUCTION

While most patients with mantle cell lymphoma (MCL) receive therapy shortly after diagnosis, a subset of patients with indolent-behaving disease can safely defer treatment. In this subgroup, we evaluated the importance of treatment intensity in patients with MCL who defer initial therapy.

METHODS

Out of 1134 patients with MCL from 12 academic centers, we analyzed 219 patients who initiated therapy at least 90 days after diagnosis. Patients who received induction with high-dose cytarabine and/or autologous stem cell transplantation (ASCT) in first remission were considered to have received intensive therapy (n = 88) while all other approaches were non-intensive (n = 131).

RESULTS

There was no difference in progression-free (PFS; P = .224) or overall survival (OS; P = .167) in deferred patients who received non-intensive vs. intensive therapy. Additionally, univariate and multivariate Cox proportional hazards models were performed for PFS and OS. Treatment at an academic center (HR 0.43, P = .015) was associated with improved OS in both univariate and multivariate models, while intensity of treatment was not associated with improved OS in either model.

CONCLUSIONS

These results indicate that intensified initial treatment is not associated with improved survival after deferring initial therapy, although prospective studies are needed to determine which of these patients with MCL may benefit from intensive therapy.

Для цитирования: Shanmugasundaram Krithika, Goyal Subir, Switchenko Jeffery, Calzada Oscar, Churnetski Michael C, Kolla Bhaskar, Bachanova Veronika, Gerson James N, Barta Stefan K, Gordon Max J, Danilov Alexey V, Grover Natalie S, Mathews Stephanie, Burkart Madelyn, Karmali Reem, Sawalha Yazeed, Hill Brian T, Ghosh Nilanjan, Park Steven I, Epperla Narendranath, Bond David A, Badar Talha, Blum Kristie A, Hamadani Mehdi, Fenske Timothy S, Malecek Mary, Kahl Brad S, Martin Peter, Guo Jin, Flowers Christopher R, Cohen Jonathon B. Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.. European journal of haematology. 2021. DOI: 10.1111/ejh.13649.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.